CHIRON CAPITAL MANAGEMENT, LLC XBI Holdings History
CHIRON CAPITAL MANAGEMENT, LLC's SPDR Biotech ETF Holding Summary
As of 2025-03-31, CHIRON CAPITAL MANAGEMENT, LLC held 83,895.00 shares of SPDR Biotech ETF(XBI), totaling $6.80 Mil. This investment constitutes 6.18% of their stock portfolio, and CHIRON CAPITAL MANAGEMENT, LLC now holds 0.13% of the outstanding SPDR Biotech ETF(XBI) stock.
The initial trade took place in 2020Q3. And since then CHIRON CAPITAL MANAGEMENT, LLC has made 8 purchases of XBI, at an average price of $98.32, for a total of 196,885.00 shares. In addition, there have been 10 sales at an average price of $88.09 for 112,990.00 shares. Based on historical transaction data and XBI's current price of $83.01, CHIRON CAPITAL MANAGEMENT, LLC's estimated gain on his XBI holdings is $-2.44 Mil, reflecting a -12.61% gain to date.
CHIRON CAPITAL MANAGEMENT, LLC XBI ($83.01) Holding Chart
CHIRON CAPITAL MANAGEMENT, LLC XBI ($83.01) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1